Cargando…
Monitored Anesthesia Care with Dexmedetomidine Supplemented by Midazolam/Fentanyl versus Midazolam/Fentanyl Alone in Patients Undergoing Pleuroscopy: Effect on Oxygenation and Respiratory Function
Although pleuroscopy is considered a safe and well tolerated procedure with a low complication rate, it requires the administration of procedural sedation and analgesia. The purpose of this study was to assess the effects of dexmedetomidine administration on oxygenation and respiratory function in p...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396832/ https://www.ncbi.nlm.nih.gov/pubmed/34441805 http://dx.doi.org/10.3390/jcm10163510 |
_version_ | 1783744465316347904 |
---|---|
author | Kostroglou, Andreas Kapetanakis, Emmanouil I. Matsota, Paraskevi Tomos, Periklis Kostopanagiotou, Konstantinos Tomos, Ioannis Siristatidis, Charalampos Papapanou, Michail Sidiropoulou, Tatiana |
author_facet | Kostroglou, Andreas Kapetanakis, Emmanouil I. Matsota, Paraskevi Tomos, Periklis Kostopanagiotou, Konstantinos Tomos, Ioannis Siristatidis, Charalampos Papapanou, Michail Sidiropoulou, Tatiana |
author_sort | Kostroglou, Andreas |
collection | PubMed |
description | Although pleuroscopy is considered a safe and well tolerated procedure with a low complication rate, it requires the administration of procedural sedation and analgesia. The purpose of this study was to assess the effects of dexmedetomidine administration on oxygenation and respiratory function in patients undergoing diagnostic or therapeutic pleuroscopy. Through a prospective, single center, cohort study, we studied 55 patients receiving either a dexmedetomidine intravenous infusion supplemented by midazolam/fentanyl (Group DEX + MZ/F) or a conventional sedation protocol with midazolam/fentanyl (Group MZ/F). Our primary outcome was the changes in lung gas exchange (PaO(2)/FiO(2) ratio) obtained at baseline and at predetermined end points, while changes in respiratory mechanics (FEV1, FVC and the ratio FEV1/FVC) and PaCO(2) levels, drug consumption, time to recover from sedation and adverse events were our secondary endpoints (NCT03597828). We found a lower postoperative decrease in FEV1 volumes in Group DEX + MZ/F compared to Group MZ/F (p = 0.039), while FVC, FEV1/FVC and gas exchange values did not differ between groups. We also found a significant reduction in midazolam (p < 0.001) and fentanyl consumption (p < 0.001), along with a more rapid recovery of alertness postprocedure in Group DEX + MZ/F compared to Group MZ/F (p = 0.003), while pain scores during the postoperative period, favored the Group DEX + MZ/F (p = 0.020). In conclusion, the use of intravenous dexmedetomidine during pleuroscopy is associated with a smaller decrease in FEV1, reduction of the consumption of supplementary sedatives and analgesics and quicker awakening of patients postoperatively, when compared to midazolam/fentanyl. Therefore, dexmedetomidine administration may provide clinically significant benefits in terms of lung mechanics and faster recovery of patients undergoing pleuroscopy. |
format | Online Article Text |
id | pubmed-8396832 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83968322021-08-28 Monitored Anesthesia Care with Dexmedetomidine Supplemented by Midazolam/Fentanyl versus Midazolam/Fentanyl Alone in Patients Undergoing Pleuroscopy: Effect on Oxygenation and Respiratory Function Kostroglou, Andreas Kapetanakis, Emmanouil I. Matsota, Paraskevi Tomos, Periklis Kostopanagiotou, Konstantinos Tomos, Ioannis Siristatidis, Charalampos Papapanou, Michail Sidiropoulou, Tatiana J Clin Med Article Although pleuroscopy is considered a safe and well tolerated procedure with a low complication rate, it requires the administration of procedural sedation and analgesia. The purpose of this study was to assess the effects of dexmedetomidine administration on oxygenation and respiratory function in patients undergoing diagnostic or therapeutic pleuroscopy. Through a prospective, single center, cohort study, we studied 55 patients receiving either a dexmedetomidine intravenous infusion supplemented by midazolam/fentanyl (Group DEX + MZ/F) or a conventional sedation protocol with midazolam/fentanyl (Group MZ/F). Our primary outcome was the changes in lung gas exchange (PaO(2)/FiO(2) ratio) obtained at baseline and at predetermined end points, while changes in respiratory mechanics (FEV1, FVC and the ratio FEV1/FVC) and PaCO(2) levels, drug consumption, time to recover from sedation and adverse events were our secondary endpoints (NCT03597828). We found a lower postoperative decrease in FEV1 volumes in Group DEX + MZ/F compared to Group MZ/F (p = 0.039), while FVC, FEV1/FVC and gas exchange values did not differ between groups. We also found a significant reduction in midazolam (p < 0.001) and fentanyl consumption (p < 0.001), along with a more rapid recovery of alertness postprocedure in Group DEX + MZ/F compared to Group MZ/F (p = 0.003), while pain scores during the postoperative period, favored the Group DEX + MZ/F (p = 0.020). In conclusion, the use of intravenous dexmedetomidine during pleuroscopy is associated with a smaller decrease in FEV1, reduction of the consumption of supplementary sedatives and analgesics and quicker awakening of patients postoperatively, when compared to midazolam/fentanyl. Therefore, dexmedetomidine administration may provide clinically significant benefits in terms of lung mechanics and faster recovery of patients undergoing pleuroscopy. MDPI 2021-08-09 /pmc/articles/PMC8396832/ /pubmed/34441805 http://dx.doi.org/10.3390/jcm10163510 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kostroglou, Andreas Kapetanakis, Emmanouil I. Matsota, Paraskevi Tomos, Periklis Kostopanagiotou, Konstantinos Tomos, Ioannis Siristatidis, Charalampos Papapanou, Michail Sidiropoulou, Tatiana Monitored Anesthesia Care with Dexmedetomidine Supplemented by Midazolam/Fentanyl versus Midazolam/Fentanyl Alone in Patients Undergoing Pleuroscopy: Effect on Oxygenation and Respiratory Function |
title | Monitored Anesthesia Care with Dexmedetomidine Supplemented by Midazolam/Fentanyl versus Midazolam/Fentanyl Alone in Patients Undergoing Pleuroscopy: Effect on Oxygenation and Respiratory Function |
title_full | Monitored Anesthesia Care with Dexmedetomidine Supplemented by Midazolam/Fentanyl versus Midazolam/Fentanyl Alone in Patients Undergoing Pleuroscopy: Effect on Oxygenation and Respiratory Function |
title_fullStr | Monitored Anesthesia Care with Dexmedetomidine Supplemented by Midazolam/Fentanyl versus Midazolam/Fentanyl Alone in Patients Undergoing Pleuroscopy: Effect on Oxygenation and Respiratory Function |
title_full_unstemmed | Monitored Anesthesia Care with Dexmedetomidine Supplemented by Midazolam/Fentanyl versus Midazolam/Fentanyl Alone in Patients Undergoing Pleuroscopy: Effect on Oxygenation and Respiratory Function |
title_short | Monitored Anesthesia Care with Dexmedetomidine Supplemented by Midazolam/Fentanyl versus Midazolam/Fentanyl Alone in Patients Undergoing Pleuroscopy: Effect on Oxygenation and Respiratory Function |
title_sort | monitored anesthesia care with dexmedetomidine supplemented by midazolam/fentanyl versus midazolam/fentanyl alone in patients undergoing pleuroscopy: effect on oxygenation and respiratory function |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396832/ https://www.ncbi.nlm.nih.gov/pubmed/34441805 http://dx.doi.org/10.3390/jcm10163510 |
work_keys_str_mv | AT kostroglouandreas monitoredanesthesiacarewithdexmedetomidinesupplementedbymidazolamfentanylversusmidazolamfentanylaloneinpatientsundergoingpleuroscopyeffectonoxygenationandrespiratoryfunction AT kapetanakisemmanouili monitoredanesthesiacarewithdexmedetomidinesupplementedbymidazolamfentanylversusmidazolamfentanylaloneinpatientsundergoingpleuroscopyeffectonoxygenationandrespiratoryfunction AT matsotaparaskevi monitoredanesthesiacarewithdexmedetomidinesupplementedbymidazolamfentanylversusmidazolamfentanylaloneinpatientsundergoingpleuroscopyeffectonoxygenationandrespiratoryfunction AT tomosperiklis monitoredanesthesiacarewithdexmedetomidinesupplementedbymidazolamfentanylversusmidazolamfentanylaloneinpatientsundergoingpleuroscopyeffectonoxygenationandrespiratoryfunction AT kostopanagiotoukonstantinos monitoredanesthesiacarewithdexmedetomidinesupplementedbymidazolamfentanylversusmidazolamfentanylaloneinpatientsundergoingpleuroscopyeffectonoxygenationandrespiratoryfunction AT tomosioannis monitoredanesthesiacarewithdexmedetomidinesupplementedbymidazolamfentanylversusmidazolamfentanylaloneinpatientsundergoingpleuroscopyeffectonoxygenationandrespiratoryfunction AT siristatidischaralampos monitoredanesthesiacarewithdexmedetomidinesupplementedbymidazolamfentanylversusmidazolamfentanylaloneinpatientsundergoingpleuroscopyeffectonoxygenationandrespiratoryfunction AT papapanoumichail monitoredanesthesiacarewithdexmedetomidinesupplementedbymidazolamfentanylversusmidazolamfentanylaloneinpatientsundergoingpleuroscopyeffectonoxygenationandrespiratoryfunction AT sidiropouloutatiana monitoredanesthesiacarewithdexmedetomidinesupplementedbymidazolamfentanylversusmidazolamfentanylaloneinpatientsundergoingpleuroscopyeffectonoxygenationandrespiratoryfunction |